David Beers, PhD

Associate Research Professor of Neurology, Institute for Academic Medicine
Associate Research Member, Research Institute
Houston Methodist

dbeers@houstonmethodist.org

VIEW RESEARCH
NETWORK

Publications

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies

Beers, D & Appel, SH 2019, The Lancet Neurology, vol. 18, no. 2, pp. 211-220. https://doi.org/10.1016/S1474-4422(18)30394-6

Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain

Zanotti Fregonara, P, Pascual, MB, Veronese, M, Yu, MM, Beers, D, Appel, SH & Masdeu, JC 2019, European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-019-04349-w

Functional alterations of myeloid cells during the course of Alzheimer's disease

Thome, AD, Faridar, A, Beers, DR, Thonhoff, JR, Zhao, W, Wen, S, Pascual, B, Masdeu, JC & Appel, SH 2018, Molecular Neurodegeneration, vol. 13, no. 1, pp. 61. https://doi.org/10.1186/s13024-018-0293-1

Head-to-head comparison of 11C-PBR28 and 18F-GE180 for quantification of the translocator protein in the human brain

Zanotti-Fregonara, P, Pascual, B, Rizzo, G, Yu, M, Pal, N, Beers, D, Carter, R, Appel, SH, Atassi, N & Masdeu, JC 2018, Journal of Nuclear Medicine, vol. 59, no. 8, pp. 1260-1266. https://doi.org/10.2967/jnumed.117.203109

Expanded autologous regulatory T-lymphocyte infusions in ALS A phase I, first-in-human study

Thonhoff, JR, Beers, DR, Zhao, W, Pleitez, M, Simpson, EP, Berry, JD, Cudkowicz, ME & Appel, SH 2018, Neurology: Neuroimmunology and NeuroInflammation, vol. 5, no. 4, e465, pp. e465. https://doi.org/10.1212/NXI.0000000000000465

Expanded autologous regulatory T-lymphocyte infusions in ALS

Thonhoff, JR, Beers, DR, Zhao, W, Pleitez, M, Simpson, EP, Berry, JD, Cudkowicz, ME & Appel, SH 2018, Neurology - Neuroimmunology Neuroinflammation, vol. 5, no. 4.

The role of regulatory T lymphocytes in amyotrophic lateral sclerosis

Beers, D, Zhao, W & Appel, SH 2018, JAMA Neurology, vol. 75, no. 6, pp. 656-658. https://doi.org/10.1001/jamaneurol.2018.0043

An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis

Fournier, CN, Schoenfeld, D, Berry, JD, Cudkowicz, ME, Chan, J, Quinn, C, Brown, RH, Salameh, JS, Tansey, MG, Beers, D, Appel, SH & Glass, JD 2018, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1-8. https://doi.org/10.1080/21678421.2017.1421666

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

Zhao, W, Beers, DR, Hooten, KG, Sieglaff, DH, Zhang, A, Kalyana-Sundaram, S, Traini, CM, Halsey, WS, Hughes, AM, Sathe, GM, Livi, GP, Fan, GH & Appel, SH 2017, JAMA Neurology, vol. 74, no. 6, pp. 677-685. https://doi.org/10.1001/jamaneurol.2017.0357

ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity

Beers, DR, Zhao, W, Wang, J, Zhang, X, Wen, S, Neal, D, Thonhoff, JR, Alsuliman, AS, Shpall, EJ, Rezvani, K & Appel, SH 2017, JCI Insight, vol. 2, no. 5, pp. e89530. https://doi.org/10.1172/jci.insight.89530

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy

Alsuliman, A, Appel, SH, Beers, DR, Basar, R, Shaim, H, Kaur, I, Zulovich, J, Yvon, E, Muftuoglu, M, Imahashi, N, Kondo, K, Liu, E, Shpall, EJ & Rezvani, K 2016, Cytotherapy, vol. 18, no. 10, pp. 1312-1324. https://doi.org/10.1016/j.jcyt.2016.06.012

TDP-43 activates microglia through NF-?B and NLRP3 inflammasome

Zhao, W, Beers, DR, Bell, S, Wang, J, Wen, S, Baloh, RH & Appel, SH 2015, Experimental Neurology, vol. 273, pp. 24-35. https://doi.org/10.1016/j.expneurol.2015.07.019

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis

Hooten, KG, Beers, D, Zhao, W & Appel, SH 2015, Neurotherapeutics, vol. 12, no. 2, pp. 364-375. https://doi.org/10.1007/s13311-014-0329-3

The Role of Regulatory T Cells and Microglia in Amyotrophic Lateral Sclerosis

Beers, D, Zhao, W, Hooten, KG & Appel, SH 2015, . in S David (ed.), Neuroinflammation: New Insights into Beneficial and Detrimental Functions. Wiley, pp. 235-249. https://doi.org/10.1002/9781118732748.ch15

Role of Inflammation in Neurodegenerative Diseases

Appel, SH, Beers, D & Zhao, W 2014, . in Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. Elsevier, pp. 380-395. https://doi.org/10.1016/B978-0-12-398270-4.00025-2

Neuroimmunology of Amyotrophic Lateral Sclerosis

Henkel, JS, Beers, D, Zhao, W & Appel, SH 2014, . in Neuroinflammation and CNS Disorders. Wiley, pp. 185-209. https://doi.org/10.1002/9781118406557.ch8

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis

Zhao, W, Beers, D & Appel, SH 2013, Journal of Neuroimmune Pharmacology, vol. 8, no. 4, pp. 888-899. https://doi.org/10.1007/s11481-013-9489-x

Erratum: Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival [EMBO Mol Med 5, 1] DOI: 10.1002/emmm.201201544

Henkel, JS, Beers, D, Wen, S, Rivera, AL, Toennis, KM, Appel, JE, Zhao, W, Moore, DH, Powell, SZ-E & Appel, SH 2013, EMBO Molecular Medicine, vol. 5, no. 2. https://doi.org/10.1002/emmm.201390002

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

Henkel, JS, Beers, D, Wen, S, Rivera, AL, Toennis, KM, Appel, JE, Zhao, W, Moore, DH, Powell, SZ-E & Appel, SH 2013, EMBO Molecular Medicine, vol. 5, no. 1, pp. 64-79. https://doi.org/10.1002/emmm.201201544

Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms

Zhao, W, Beers, D, Liao, B, Henkel, JS & Appel, SH 2012, Neurobiology of Disease, vol. 48, no. 3, pp. 418-428. https://doi.org/10.1016/j.nbd.2012.07.008

VIEW FULL PUBLICATIONS